AHL Partners’s PRA Health Sciences, Inc. PRAH Stock Holding History

AHL Partners’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$1.11M	Sell	12,196 -39,094	-76%	-$3.25M	0.02%	861
2017 Q3	$3.91M	Buy	51,290 +21,645	+73%	+$1.64M	0.07%	458
2017 Q2	$2.22M	Buy	29,645 +7,263	+32%	+$503K	0.05%	592
2017 Q1	$1.46M	Buy	22,382 +14,496	+184%	+$854K	0.03%	699
2016 Q4	$434K	Sell	7,886 -4,473	-36%	-$245K	0.01%	896
2016 Q3	$699K	Sell	12,359 -3,148	-20%	-$154K	0.03%	702
2016 Q2	$648K	Buy	15,507 +4,116	+36%	+$190K	0.04%	547
2016 Q1	$487K	Buy	+11,391	New	+$481K	0.03%	580

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AHL Partners's PRAH Position: Q4 2017 in Review

AHL Partners reduced its PRA Health Sciences, Inc. (PRAH) stake by 76% in Q4 2017, selling an estimated $3.25M and leaving 12,196 shares worth $1.11M. The position accounts for 0.02% of the portfolio, ranked #861.

AHL Partners first reported a position in PRAH in Q1 2016 and has held it in 8 quarters since. The position peaked at $3.91M in Q3 2017. 282 funds tracked by Wall St. Rank hold PRAH as of Q4 2017.

AHL Partners held 12,196 shares of PRA Health Sciences, Inc. worth $1.11M as of Q4 2017.
AHL Partners sold 39,094 PRA Health Sciences, Inc. shares in Q4 2017, an estimated $3.25M.
PRA Health Sciences, Inc. made up 0.02% of AHL Partners's portfolio in Q4 2017, its #861 holding.
AHL Partners first reported a position in PRA Health Sciences, Inc. in Q1 2016 and has held it in 8 quarters since.
AHL Partners's PRA Health Sciences, Inc. position peaked at $3.91M in Q3 2017.
282 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.